A mum who shed five stone in just five months using weight loss injections has claimed that the medication also helped curb ...

Now, one Wegovy user who's been on the medication for only a week has shared an unexpected side effect of the drug - but they ...

GLP-1 receptor agonists are transforming obesity and diabetes care, but may reduce skeletal muscle mass, raising concerns ...

Eli Lilly’s once-daily oral weight-loss pill is making headlines after promising trial results. But can it really match the ...

Elli Lily said on Tuesday that its daily weight loss pill helped patients lose weight, specifically those with obesity and ...

Eli Lilly's GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory ...

A competitor reported a successful late-stage clinical trial of a drug that could be very competitive with Wegovy.

GLP-1 drugs may lower the risk of some obesity-related cancers, according to an observational study of people who were ...

For Tuesday, Aug. 26, WGN’s Ben Bradley and Lourdes Duarte have the latest on new medical information, including: Eli Lilly ...

While existing GLP-1 medications have shown greater weight loss than Lilly’s oral medication, this option targets both weight loss and type 2 diabetes in patients.

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

Orforglipron will be submitted to global regulatory authorities for the treatment of obesity or for weight loss by the end of ...